AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2023
Dec 11, 2023
34105_dirs_2023-12-11_6287986a-8840-4223-8885-fa60f95db78c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2023-12-07
Reporting Person: FAIN PHILIP A (CFO and Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-07 | Stock Options for ULBI Common Stock; $.10 par Value | $ | A | 18400 | Acquired | 2030-12-07 | Stock Options for ULBI Common Stock; $.10 par Value (18400) | Direct |
Footnotes
F1: On December 7, 2023 Ultralife Corporation's Board of Directors awarded 18,400 stock options to Philip A. Fain under Ultralife's 2014 Long-Term Incentive Plan as Amended. These options vest as follows: 6,134 options vest on December 7, 2024; 6,133 options vest on December 7, 2025 and 6,133 options vest on December 7, 2026. The price reported is the volume weighted average price (VWAP) for Ultralife Common Stock on December 7, 2023, the date of award.
More from ULTRALIFE CORP
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5